Prevention: Direct FY2011 Prevention of Mother-to-Child Transmission Program Results |
Countries |
Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results)1 |
Number of HIV+ pregnant women receiving ARV prophylaxis |
Estimated infant HIV infections averted2 |
Angola |
71,700 |
900 |
266 |
Botswana3 |
NA |
NA |
NA |
Burundi |
50,100 |
400 |
142 |
Cambodia |
100,600 |
400 |
113 |
Cameroon |
NA |
NA |
NA |
China |
66,600 |
200 |
56 |
Côte d’Ivoire |
332,200 |
9,000 |
2,788 |
Democratic Republic of the Congo |
132,900 |
2,200 |
555 |
Dominican Republic |
39,600 |
300 |
107 |
Ethiopia |
815,100 |
10,300 |
3,174 |
Ghana3,4 |
29,800 |
400 |
117 |
Guyana |
11,000 |
100 |
42 |
Haiti |
176,000 |
3,500 |
1,081 |
India |
71,800 |
300 |
66 |
Indonesia4 |
NA |
NA |
NA |
Kenya |
1,189,100 |
67,300 |
20,442 |
Lesotho |
25,500 |
7,400 |
2,304 |
Malawi |
187,800 |
14,400 |
4,291 |
Mozambique |
565,900 |
43,500 |
12,653 |
Namibia |
52,200 |
7,500 |
2,293 |
Nigeria |
1,083,500 |
34,400 |
10,322 |
Russia4 |
NA |
NA |
NA |
Rwanda |
150,200 |
4,700 |
1,452 |
South Africa |
720,100 |
236,100 |
73,186 |
Sudan |
13,500 |
500 |
133 |
Swaziland |
25,800 |
9,100 |
2,810 |
Tanzania |
1,436,000 |
58,200 |
17,386 |
Thailand4 |
NA |
NA |
NA |
Uganda |
1,136,900 |
55,400 |
16,742 |
Ukraine4 |
NA |
NA |
NA |
Vietnam |
457,200 |
1,300 |
382 |
Zambia |
545,500 |
53,400 |
15,229 |
Zimbabwe |
330,800 |
39,700 |
11,946 |
Regions |
|
|
|
Caribbean Region4 |
NA |
NA |
NA |
Central America4 |
NA |
NA |
NA |
Central Asia4 |
NA |
NA |
NA |
Total |
9,817,400 |
660,900 |
200,080 |
Notes: |
Numbers may be adjusted as attribution criteria and reporting systems are refined. |
All numbers greater than 100 have been rounded off to the nearest 100. |
Footnotes: |
1This indicator has two components: 1) the number of women with known positive HIV infection attending an ANC for a new pregnancy over the last reporting period; and 2) the number of women attending ANC, Labor and Delivery sites who were tested for HIV and received results (which is also captured under the testing and counseling results). The previous PMTCT indicator: “the number of pregnant women receiving PMTCT services” included only women who were counseled and tested and received their test results. For further information, refer to Indicator P1.1.D in the PEPFAR Next Generation Indicator Guidance on http://www.pepfar.gov/guidance/index.htm. |
2FY2011 is the first year where PEPFAR PMTCT country programs reported PMTCT ARV uptake by regimen (ART for HIV-positive pregnant women eligible for treatment, maternal AZT, maternal triple ARV prophylaxis, and single dose nevirapine). With these results, the method used this year to estimate infant HIV infections averted now accounts for the different probabilities of transmission for each of the different regimens. |
3“0” refers to countries that did not directly support PMTCT programs. |
4“NA” refers to countries or regions where USG did not support PMTCT or PMTCT ARV prophylaxis programs. |